← Back to CoursesMolecular Neuroscience: PhD Level

Neuroanatomy Explorer

Drag to rotate · scroll to zoom · click regions to explore

View
Loading 3D model…

Click a region
to explore it

Memory Deck

Flip each card and rate whether you knew it. Your score is saved.

Term
Definition

Deck complete — score saved.

Match the Pairs

Match each term to its definition. Finish the board to earn your score.

All matched — score saved.

Concept Constellation

Every key idea in this course, mapped as an explorable 3D constellation. Drag to rotate, scroll to zoom, click a node.

Click a node to read its definition.

Molecular Basis of Psychiatric and Neurodevelopmental Disorders

Manual: General · Subject: Molecular Neuroscience

Synthesizes genetic, developmental, synaptic, and circuit-level molecular evidence for complex brain disorders.

From Risk Variants to Circuit Dysfunction

Overview

Psychiatric and neurodevelopmental disorders are highly polygenic and often emerge from perturbations in transcriptional regulation, synaptic development, excitation-inhibition balance, chromatin state, and experience-dependent plasticity. Molecular neuroscience aims to identify convergent pathways that translate genetic risk into altered cell states and circuit phenotypes.

Levels of Disorder Causation

Genetic risk

  • Common and rare variants
  • Often enriched in regulatory DNA and synaptic genes

Cell-state dysregulation

  • Altered transcriptional programs
  • Impaired neuronal maturation or glial support

Why are many psychiatric disorders difficult to map to a single molecular lesion?

What is one reason enhancer variants are important in psychiatric genetics?

Common Mechanistic Themes

Synaptic gene disruption
Impacts plasticity and connectivity
Chromatin dysregulation
Changes developmental gene programs
Neuron-glia imbalance
Affects support and pruning
Network-level compensation
Can mask primary molecular defects
⚠️

Interpretation Caution

Association does not equal mechanism: genetic signals often point to vulnerable cell types or pathways, but causal validation requires perturbation and phenotyping.

Open Problems

The field still needs causal links from variant to cell state to circuit to behavior, especially for polygenic risk. Another frontier is explaining why the same risk architecture can produce diverse clinical phenotypes across individuals.

From GWAS to Mechanism

  1. 1

    Step 1: Identify associated loci and credible variants.

  2. 2

    Step 2: Map variants to regulatory elements and target genes.

  3. 3

    Step 3: Test effects in relevant neural cell types or organoids.

  4. 4

    Step 4: Measure consequences at synaptic, circuit, and behavioral levels.

What is the best next step after finding a noncoding risk variant near a gene?